Carl L Gordon - Net Worth and Insider Trading
Carl L Gordon Net Worth
The estimated net worth of Carl L Gordon is at least $939 Million dollars as of 2024-07-16. Carl L Gordon is the Director, 10% Owner of Prevail Therapeutics Inc and owns about 13,822,463 shares of Prevail Therapeutics Inc (PRVL) stock worth over $318 Million. Carl L Gordon is the Director of Turning Point Therapeutics Inc and owns about 2,027,550 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $154 Million. Carl L Gordon is also the Director, 10% Owner of Terns Pharmaceuticals Inc and owns about 7,619,135 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $76 Million. Besides these, Carl L Gordon also holds Alector Inc (ALEC) , Theseus Pharmaceuticals Inc (THRX) , Intellia Therapeutics Inc (NTLA) , Keros Therapeutics Inc (KROS) , ArriVent BioPharma Inc (AVBP) , ORIC Pharmaceuticals Inc (ORIC) , Compass Therapeutics Inc (CMPX) , Adicet Bio Inc (ACET) , ACADIA Pharmaceuticals Inc (ACAD) , BioCryst Pharmaceuticals Inc (BCRX) , X4 Pharmaceuticals Inc (XFOR) , Kinnate Biopharma Inc (KNTE) , Cartesian Therapeutics Inc (RNAC) , Pacira BioSciences Inc (PCRX) . Details can be seen in Carl L Gordon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carl L Gordon has not made any transactions after 2024-01-30 and currently still holds the listed stock(s).
Transaction Summary of Carl L Gordon
Carl L Gordon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl L Gordon owns 22 companies in total, including Prevail Therapeutics Inc (PRVL) , Turning Point Therapeutics Inc (TPTX) , and ORIC Pharmaceuticals Inc (ORIC) among others .
Click here to see the complete history of Carl L Gordon’s form 4 insider trades.
Insider Ownership Summary of Carl L Gordon
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRVL | Prevail Therapeutics Inc | 2020-06-17 | director & 10 percent owner |
TPTX | Turning Point Therapeutics Inc | 2019-04-22 | director |
ORIC | ORIC Pharmaceuticals Inc | 2021-03-30 | director |
![]() | ![]() | 2020-04-13 | director |
![]() | ![]() | 2019-09-12 | director & 10 percent owner |
![]() | ![]() | 2019-02-11 | director & 10 percent owner |
![]() | ![]() | 2018-06-22 | director |
![]() | ![]() | 2017-11-20 | director & 10 percent owner |
![]() | ![]() | 2016-05-11 | director & 10 percent owner |
![]() | ![]() | 2016-06-27 | director & 10 percent owner |
![]() | ![]() | 2013-09-18 | director |
![]() | ![]() | 2011-02-28 | director |
![]() | ![]() | 2011-02-08 | director |
![]() | ![]() | 2005-12-02 | director |
![]() | ![]() | 2005-04-20 | director |
![]() | ![]() | 2024-01-25 | director |
![]() | ![]() | 2022-11-08 | director & 10 percent owner |
![]() | ![]() | 2023-07-17 | director & 10 percent owner |
![]() | ![]() | 2023-05-05 | director |
![]() | ![]() | 2021-10-04 | director & 10 percent owner |
![]() | ![]() | 2022-12-23 | director & 10 percent owner |
![]() | ![]() | 2023-02-27 | 10 percent owner |
Carl L Gordon Latest Holdings Summary
Carl L Gordon currently owns a total of 17 stocks. Among these stocks, Carl L Gordon owns 13,822,463 shares of Prevail Therapeutics Inc (PRVL) as of June 24, 2019, with a value of $318 Million and a weighting of 33.87%. Carl L Gordon owns 2,027,550 shares of Turning Point Therapeutics Inc (TPTX) as of April 22, 2019, with a value of $154 Million and a weighting of 16.42%. Carl L Gordon also owns 7,619,135 shares of Terns Pharmaceuticals Inc (TERN) as of December 23, 2022, with a value of $76 Million and a weighting of 8.11%. The other 14 stocks Alector Inc (ALEC) , Theseus Pharmaceuticals Inc (THRX) , Intellia Therapeutics Inc (NTLA) , Keros Therapeutics Inc (KROS) , ArriVent BioPharma Inc (AVBP) , ORIC Pharmaceuticals Inc (ORIC) , Compass Therapeutics Inc (CMPX) , Adicet Bio Inc (ACET) , ACADIA Pharmaceuticals Inc (ACAD) , BioCryst Pharmaceuticals Inc (BCRX) , X4 Pharmaceuticals Inc (XFOR) , Kinnate Biopharma Inc (KNTE) , Cartesian Therapeutics Inc (RNAC) , Pacira BioSciences Inc (PCRX) have a combined weighting of 41.59% among all his current holdings.
Latest Holdings of Carl L Gordon
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PRVL | Prevail Therapeutics Inc | 2019-06-24 | 13,822,463 | 23.00 | 317,916,649 |
TPTX | Turning Point Therapeutics Inc | 2019-04-22 | 2,027,550 | 76.01 | 154,114,076 |
TERN | Terns Pharmaceuticals Inc | 2022-12-23 | 7,619,135 | 9.99 | 76,115,159 |
ALEC | Alector Inc | 2019-02-11 | 13,094,029 | 5.73 | 75,028,786 |
THRX | Theseus Pharmaceuticals Inc | 2023-07-17 | 17,713,600 | 4.06 | 71,917,216 |
NTLA | Intellia Therapeutics Inc | 2016-05-11 | 2,662,180 | 26.01 | 69,243,302 |
KROS | Keros Therapeutics Inc | 2020-04-13 | 1,268,734 | 51.06 | 64,775,214 |
AVBP | ArriVent BioPharma Inc | 2024-01-30 | 1,513,664 | 19.64 | 29,728,361 |
ORIC | ORIC Pharmaceuticals Inc | 2021-03-30 | 2,212,571 | 10.75 | 23,785,138 |
CMPX | Compass Therapeutics Inc | 2022-11-08 | 18,791,422 | 1.01 | 18,979,336 |
ACET | Adicet Bio Inc | 2024-01-25 | 11,447,140 | 1.24 | 14,194,454 |
ACAD | ACADIA Pharmaceuticals Inc | 2005-04-20 | 621,606 | 18.03 | 11,207,556 |
BCRX | BioCryst Pharmaceuticals Inc | 2005-12-02 | 1,100,000 | 7.18 | 7,898,000 |
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 1,868,966 | 0.72 | 1,339,862 |
KNTE | Kinnate Biopharma Inc | 2023-05-05 | 450,000 | 2.65 | 1,192,500 |
RNAC | Cartesian Therapeutics Inc | 2016-06-27 | 60,847 | 17.88 | 1,087,944 |
PCRX | Pacira BioSciences Inc | 2011-02-08 | 0 | 21.30 | 0 |
Holding Weightings of Carl L Gordon
Carl L Gordon Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl L Gordon has made a total of 0 transactions in Prevail Therapeutics Inc (PRVL) over the past 5 years. The most-recent trade in Prevail Therapeutics Inc is the acquisition of 882,352 shares on June 24, 2019, which cost Carl L Gordon around $15 Million.
According to the SEC Form 4 filings, Carl L Gordon has made a total of 0 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years. The most-recent trade in Turning Point Therapeutics Inc is the acquisition of 360,000 shares on April 22, 2019, which cost Carl L Gordon around $6 Million.
According to the SEC Form 4 filings, Carl L Gordon has made a total of 3 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Terns Pharmaceuticals Inc is the acquisition of 137,931 shares on December 23, 2022, which cost Carl L Gordon around $1,000,000.
More details on Carl L Gordon's insider transactions can be found in the Insider Trading History of Carl L Gordon table.Insider Trading History of Carl L Gordon
- 1
Carl L Gordon Trading Performance
GuruFocus tracks the stock performance after each of Carl L Gordon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl L Gordon is 7.32%. GuruFocus also compares Carl L Gordon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl L Gordon within 3 months outperforms 15 times out of 29 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl L Gordon's insider trading performs compared to the benchmark.
Performance of Carl L Gordon
Carl L Gordon Ownership Network
Ownership Network List of Carl L Gordon
Ownership Network Relation of Carl L Gordon
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Carl L Gordon Owned Company Details
What does Prevail Therapeutics Inc do?
Who are the key executives at Prevail Therapeutics Inc?
Carl L Gordon is the director & 10 percent owner of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Peter A. Thompson , General Counsel Kira M. Schwartz , and Chief Development Officer Franz Hefti .
Prevail Therapeutics Inc (PRVL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prevail Therapeutics Inc Insider Transactions
Carl L Gordon Mailing Address
Above is the net worth, insider trading, and ownership report for Carl L Gordon. You might contact Carl L Gordon via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.